The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Serov D.N.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii DZM

The modern view on external therapy of psoriasis

Authors:

Potekaev N.N., Serov D.N.

More about the authors

Read: 3894 times


To cite this article:

Potekaev NN, Serov DN. The modern view on external therapy of psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2013;11(3):92‑96. (In Russ.)

Recommended articles:
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
New aspe­cts of psoriasis pathogenesis: meta­bolomic profiling in dermatology. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):526-531
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Key specific tools for asse­ssment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):319-325
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
New approach to clinical evaluation of nail lesions in psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):453-460

References:

  1. Buckley C., Hoffmann V., Shapiro J., Saari S., Cambazard F., Milsgaard M. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study. Dermatology 2008; 217: 107-113.
  2. Langley R., Krueger G., Griffiths C. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheumatol Dis 2005; 64: Suppl: 2: 18-23.
  3. Mrowietz U., Kramballe K., Reich K. et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.
  4. European Dermatology Forum (EDF). European S3 guidelines on the systemic treatment of psoriasis vulgaris 2009.
  5. Jemec G.B., Ganslandt C., Ortonne J.P. et al. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. J Am Acad Dermatol 2008; 59: 455-463.
  6. Luger T.A., Cambazard F., Larsen F.G. et al. A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis. Dermatology 2008; 217: 321-328.
  7. van de Kerkhof P.C., Hoffmann V., Anstey A. et al. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. Br J Dermatol 2009; 160: 170-176.
  8. Gottlieb A.B., Ford R.O., Spellman M.C. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. J Cutan Med Surg 2003; 7: 185-192.
  9. Poulin Y., Papp K., Bissonnette R. et al. Safe and effective long-term control of moderate scalp psoriasis with clobetasol propionate shampoo 0.05%. Manuscript in preparation 2008.
  10. Smith C.H., Anstey A.V., Barker J.N. et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009; 161: 5: 987-1019.
  11. Papp K. et al. Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population. J Am Acad Dtrmatol 2010; 1016-1026.
  12. Sabat R., Philipp S., Höflich C. et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007; 16: 10: 779-798.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.